Related Experiment Video
Updated: Nov 18, 2025

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells
Published on: December 27, 2017
Pseudothrombocytopenia-A Review on Causes, Occurrence and Clinical Implications
Benjamin Lardinois1, Julien Favresse1, Bernard Chatelain1
1Namur Thrombosis and Hemostasis Center (NTHC), CHU UCL Namur, Université Catholique de Louvain, 5530 Yvoir, Belgium.
Pseudothrombocytopenia (PTCP) is a common lab finding that can cause errors and unnecessary treatments. This review explores PTCP causes, implications, and proposes a lab approach to manage spurious low platelet counts.
Area of Science:
- Hematology
- Clinical Pathology
- Laboratory Medicine
Background:
- Pseudothrombocytopenia (PTCP) is a frequent laboratory finding with potential for significant clinical misdiagnosis.
- Undetected PTCP can lead to overtreatment, including unnecessary platelet transfusions or invasive procedures.
- The complexity of PTCP is amplified by its association with various anticoagulants.
Purpose of the Study:
- To review the phenomenon of pseudothrombocytopenia (PTCP), focusing on anticoagulant-dependent cases.
- To discuss the prevalence, risk factors, and clinical implications of PTCP.
- To propose a practical laboratory approach for managing spurious low platelet counts.
Main Methods:
- Case presentation of multi-anticoagulant PTCP.
- Investigation of parameters such as temperature, amikacin supplementation, measurement methods, and anticoagulant type.
- Review of existing literature on PTCP prevalence, risk factors, and analytical considerations.
Main Results:
- Anticoagulant-dependent PTCP can occur, influenced by various pre-analytical and analytical factors.
- PTCP incidence appears higher in patients on low molecular weight heparin, during hospitalization, and in older men.
- New analytical technologies are emerging to aid in PTCP detection.
Conclusions:
- Detection of anticoagulant-dependent PTCP requires careful laboratory investigation.
- PTCP does not always indicate underlying hematological disorders.
- A structured laboratory approach is crucial for accurate platelet count assessment and patient management.
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis I: Introduction
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...

